- Home
- FSBC vs XNCR Comparison
FSBC vs XNCR Comparison
Compare FSBC & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSBC
- XNCR
- Stock Information
- Founded
- FSBC 2002
- XNCR 1997
- Country
- FSBC United States
- XNCR United States
- Employees
- FSBC N/A
- XNCR N/A
- Industry
- FSBC Banks
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- FSBC Finance
- XNCR Health Care
- Exchange
- FSBC Nasdaq
- XNCR Nasdaq
- Market Cap
- FSBC 603.9M
- XNCR 579.3M
- IPO Year
- FSBC 2021
- XNCR 2013
- Fundamental
- Price
- FSBC $26.48
- XNCR $8.54
- Analyst Decision
- FSBC Buy
- XNCR Buy
- Analyst Count
- FSBC 4
- XNCR 7
- Target Price
- FSBC $34.75
- XNCR $27.50
- AVG Volume (30 Days)
- FSBC 46.6K
- XNCR 855.3K
- Earning Date
- FSBC 07-23-2025
- XNCR 08-04-2025
- Dividend Yield
- FSBC 3.02%
- XNCR N/A
- EPS Growth
- FSBC N/A
- XNCR N/A
- EPS
- FSBC 2.27
- XNCR N/A
- Revenue
- FSBC $124,973,000.00
- XNCR $127,228,000.00
- Revenue This Year
- FSBC $25.86
- XNCR N/A
- Revenue Next Year
- FSBC $15.15
- XNCR $28.84
- P/E Ratio
- FSBC $11.66
- XNCR N/A
- Revenue Growth
- FSBC 11.14
- XNCR N/A
- 52 Week Low
- FSBC $22.22
- XNCR $7.16
- 52 Week High
- FSBC $35.13
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- FSBC 37.75
- XNCR 44.94
- Support Level
- FSBC $26.20
- XNCR $8.05
- Resistance Level
- FSBC $28.70
- XNCR $10.20
- Average True Range (ATR)
- FSBC 0.82
- XNCR 0.57
- MACD
- FSBC -0.17
- XNCR -0.01
- Stochastic Oscillator
- FSBC 9.86
- XNCR 31.40
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.